Cargando…

CHA(2)DS(2)-VASc score and left atrial volume dilatation synergistically predict incident atrial fibrillation in hypertension: an observational study from the Campania Salute Network registry

Arterial hypertension is a leading risk factor for developing atrial fibrillation. CHA(2)DS(2)-VASc score can help to decide if patients with atrial fibrillation need anticoagulation. Whether CHA(2)DS(2)-VASc may predicts incident atrial fibrillation and how it interacts with left atrial dilatation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rapacciuolo, Antonio, Mancusi, Costantino, Canciello, Grazia, Izzo, Raffaele, Strisciuglio, Teresa, de Luca, Nicola, Ammirati, Giuseppe, de Simone, Giovanni, Trimarco, Bruno, Losi, Maria-Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536498/ https://www.ncbi.nlm.nih.gov/pubmed/31133712 http://dx.doi.org/10.1038/s41598-019-44214-2

Ejemplares similares

Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network)
por: Lønnebakken, Mai Tone, et al.
Publicado: (2017)

Carotid Atherosclerosis Predicts Blood Pressure Control in Patients With Hypertension: The Campania Salute Network Registry
por: Mancusi, Costantino, et al.
Publicado: (2022)

Beyond CHA(2)DS(2)-VASc in atrial fibrillation: the atrium and the risk of stroke
por: Boccanelli, Alessandro
Publicado: (2020)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

High CHA(2)DS(2)-VASc score without atrial fibrillation: ‘NAO yes, NAO no’
por: Perna, Gian Piero
Publicado: (2019)

CHA(2)DS(2)-VASc score stratifies mortality risk in patients with and without atrial fibrillation
por: Harb, Serge C, et al.
Publicado: (2021)

CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016)

Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA(2)DS(2)-VASc Score
por: Lin, Yu-Sheng, et al.
Publicado: (2018)

The CHA(2)DS(2)-VASc Score as a Predictor of Left Atrial Thrombus in Patients with Non-Valvular Atrial Fibrillation
por: Uz, Omer, et al.
Publicado: (2014)

Inverse Correlation Between Left Atrial Appendage Function and CHA(2)DS(2)-VASc Score in Patients with Atrial Flutter
por: Wu, Mei-Yao, et al.
Publicado: (2019)

Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA(2)DS(2)-VASc score
por: Yan, Shuangbing, et al.
Publicado: (2019)

The association of CHA(2)DS(2)-VASc score and carotid plaque in patients with non-valvular atrial fibrillation
por: Shang, Luxiang, et al.
Publicado: (2019)

Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
por: Tomasdottir, Maria, et al.
Publicado: (2019)

The relationship of the serum endocan level with the CHA(2)DS(2)-VASc score in patients with paroxysmal atrial fibrillation
por: Ceyhun, Gökhan
Publicado: (2021)

Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrillation Patients
por: Fang, Chen, et al.
Publicado: (2022)

Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation
por: Tsiartas, Eirinaios, et al.
Publicado: (2023)

ACC/AHA Hypertension Guidelines and CHA(2)DS(2)-VASc Up-Scoring in Patients With Atrial Fibrillation
por: Pundi, Krishna, et al.
Publicado: (2023)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

CHA(2)DS(2)-VASc Score as a Predictor of New-Onset Atrial Fibrillation After Catheter Ablation of Typical Atrial Flutter
por: Liu, Fei, et al.
Publicado: (2020)

Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS(2)/CHA(2)DS(2)VASc Score
por: Hung, Chen-Ying, et al.
Publicado: (2014)

Assessment of CHADS(2) and CHA(2)DS(2)-VASc scores in obstructive sleep apnea patients with atrial fibrillation
por: Szymanski, Filip M., et al.
Publicado: (2014)

Use of the CHA(2)DS(2)VASc score to reduce utilisation of transoesophageal echocardiography prior to ablation for atrial fibrillation
por: Atkinson, Charlotte, et al.
Publicado: (2017)

Can men with atrial fibrillation really rest easy with a CHA(2)DS(2)-VASc score of 0?
por: Cheng, Chen-Di, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc score, cerebral small vessel disease, and frailty in older patients with atrial fibrillation
por: Choi, Jung-Yeon, et al.
Publicado: (2020)

Impact of timing of atrial fibrillation, CHA(2)DS(2)-VASc score and cancer therapeutics on mortality in oncology patients
por: Hussain, Muzna, et al.
Publicado: (2020)

Association of CHA(2)DS(2)-VASc Score With Remodeling of Left Atrial Appendage Assessed by Cardiac Computed Tomography
por: Cecconi, Alberto, et al.
Publicado: (2021)

Stroke and Systemic Thromboembolism according to CHA(2)DS(2)-VASc Score in Contemporary Korean Patients with Atrial Fibrillation
por: Lee, Kyung Bae, et al.
Publicado: (2022)

Left atrial function as a predictor of stroke or systemic embolism: Beyond the CHA(2)DS(2)‐VASc score
por: Murat, Bektas, et al.
Publicado: (2023)

CHA(2)DS(2)-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting
por: ZHENG, Jian-Yong, et al.
Publicado: (2022)

Mortality Prediction of the CHA(2)DS(2)-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation
por: Morrone, Doralisa, et al.
Publicado: (2020)

Total Adiponectin Is Inversely Associated with Platelet Activation and CHA(2)DS(2)-VASc Score in Anticoagulated Patients with Atrial Fibrillation
por: Carnevale, Roberto, et al.
Publicado: (2014)

Silent cerebral infarcts in patients with atrial fibrillation: Clinical implications of an imaging-adjusted CHA(2)DS(2)-VASc score
por: Bretzman, John P., et al.
Publicado: (2022)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

Relationship of CHA(2)DS(2)-VASc and CHADS(2) Score to Left Atrial Remodeling Detected by Velocity Vector Imaging in Patients with Atrial Fibrillation
por: Li, Yihui, et al.
Publicado: (2013)

Predictive Values of the CHA2DS2-VASc Score and Left Atrial Diameter for Cerebral Small Vessel Disease in Geriatric Patients With Atrial Fibrillation
por: Tanburoglu, Anıl, et al.
Publicado: (2023)

CHADS(2) and CHA(2)DS(2)-VASc Scoring Systems for Predicting Atrial Fibrillation following Cardiac Valve Surgery
por: Yin, Liang, et al.
Publicado: (2015)

Predictive value of CHADS(2) and CHA(2)DS(2)-VASc scores for acute myocardial infarction in patients with atrial fibrillation
por: Pang, Hui, et al.
Publicado: (2017)

The Validation of the ATRIA and CHA2DS2-Vasc Scores in Predicting Atrial Fibrillation after Coronary Artery Bypass Surgery
por: Uysal, Dinçer, et al.
Publicado: (2020)

Left atrial spontaneous echo contrast occurring in patients with low CHADS(2) or CHA(2)DS(2)-VASc scores
por: Akamatsu, Kanako, et al.
Publicado: (2020)

The Extended Utility of CHA(2)DS(2)VASc and HAS-BLED Scores in the Selection for Transcutaneous Left Atrial Appendage Closure
por: Streb, Witold, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h26q495o8gqeg7558eufgi96lg